Table 3.
Correlates of Lost to Follow-Up on Univariate Analysis
| |
Correlates of LTFU (new enrollments) |
Correlates of LTFU (on ART for >2 years) |
||
|---|---|---|---|---|
| Hazard ratio 95% CI | p | Hazard ratio 95% CI | p | |
| Age | 1.11 (1.08–1.13) | <0.001 | 1.10 (1.08–1.13) | <0.001 |
| Age group (years) | ||||
| 10–14 | Ref. | Ref. | ||
| 15–19 | 2.12 (1.44–3.11) | <0.001 | 1.29 (1.01–1.66) | 0.042 |
| 20–24 | 3.35 (2.39–4.69) | <0.001 | 2.84 (2.27–3.56) | <0.001 |
| Female | 1.73 (1.34–2.22) | <0.001 | 1.49 (1.22–1.80) | <0.001 |
| Marital status (if age ≥18) | ||||
| Single | Ref. | Ref. | ||
| Married/cohabiting | 1.06 (0.87–1.29) | 0.568 | 1.61 (1.25–2.09) | <0.001 |
| Divorced or widowed | 1.71 (1.15–2.54) | 0.008 | 2.07 (1.17–3.65) | 0.012 |
| Entry point | ||||
| PMTCT/VCT/MCH | Ref. | Ref. | ||
| OPD/IPD/TB clinic | 0.74 (0.61–0.91) | 0.004 | 0.72 (0.55–0.95) | 0.018 |
| Support person | ||||
| Parent | Ref. | Ref. | ||
| Spouse | 1.65 (1.34–2.05) | <0.001 | 2.41 (1.89–3.08) | <0.001 |
| Other | 1.47 (1.16–1.88) | 0.002 | 1.20 (0.96–1.50) | 0.118 |
| Age at ART initiation | 1.13 (1.10–1.16) | <0.001 | 1.08 (1.06–1.10) | <0.001 |
| Perinatal HIVa | 0.35 (0.25–0.49) | <0.001 | 0.40 (0.33–0.48) | <0.001 |
| WHO stage at enrollment | ||||
| Stage I/II | Ref. | Ref. | ||
| Stage III/IV | 0.64 (0.42–0.98) | 0.040 | 0.66 (0.52–0.84) | 0.001 |
| Last visit characteristics | ||||
| WHO stage | ||||
| Stage I/II | Ref. | Ref. | ||
| Stage III/IV | 0.68 (0.46–1.02) | 0.061 | 0.57 (0.40–0.81) | 0.002 |
| Pregnant | 1.97 (1.43–2.73) | 0.001 | 0.96 (0.43–2.12) | 0.919 |
ART regimen not included due to few outcomes.
a
ART initiated at less than 12 years of age.
Values in bold are correlates of mortality among new enrollments and on ART >2 years that are statistically significant.
LTFU, loss to follow-up.